Tuesday Aug 12
Manhunt on for bar co-founder wanted in executive's shooting death
Police are searching for the co-founder of a Minneapolis bar who is a suspect in the fatal shooting of his former business partner, a Boston Scientific executive.
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces...
Such investors are advised to contact Boston Scientific disclosed in a regulatory filing that it received a "subpoena from the U.S. Attorney for the District of , including information relating to its sale of CrossBoss and Stingray products, educational and training activities that relate to those sales and our acquisition of BridgePoint Medical."
Boston Scientific prevails in first of thousands of mesh lawsuits
Shares in Boston Scientific shot up this afternoon following the news that the medical device company has been found not liable in the first of thousands of lawsuits over its transvaginal mesh.
Boston Scientific Now Covered by Sterne Agee
The firm set a "neutral" rating and a $13.50 price target on the stock. Sterne Agee's price objective suggests a potential upside of 4.09% from the stock's previous close.
Boston Scientific Receives FDA Approval for REBEL(TM) Platinum Chromium Coronary Stent System
Boston Scientific Corporation has received FDA approval for the REBEL Platinum Chromium Coronary Stent System, the company's latest generation bare-metal stent for the treatment of coronary artery disease .